Results 181 to 190 of about 33,345 (227)

Association of Serum Creatinine-Cystatin C Ratio With Hospital-Associated Complications and Post-Discharge Mortality. [PDF]

Geriatr Gerontol Int
Yamada Y, Nakashima H, Nagae M, Watanabe K, Fujisawa C, Komiya H, Tajima T, Sakai T, Satake S, Umegaki H.   +9 more
europepmc   +1 more source

Discrepancy between cystatin C-based and creatinine-based eGFR predicts all-cause mortality in a community-based population: the Takahata study. [PDF]

Clin Exp Nephrol
Suzuki T, Ichikawa K, Suzuki N, Watanabe M, Konta T.   +4 more
europepmc   +1 more source

Oligomeric cystatin C supports the immunosuppressive activity of myeloid cells through interaction with inhibitory receptors. [PDF]

Signal Transduct Target Ther
Zhang C, He Y, Liu X, Xie J, Fang M, Yang X, Huang R, Lou Q, Li B, Gupta A, Lewis C, Diamond MI, Zhang N, An Z, Zhang CC.   +14 more
europepmc   +1 more source

[Cystatin C: yes, but...].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2007
openaire   +1 more source

No mutations in cystatin C gene in cerebral amyloid angiopathy with cystatin C deposition

, 1997
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cystatin C and intravenous thrombolysis

European Journal of Neurology, 2021
With great interest, we read the recent original article written by Zihan Chang et al1 , which was published in European Journal of Neurology. In this multicenter retrospective case-control study, the authors found that elevated serum Cystatin C may be associated with unfavorable clinical outcomes after intravenous tissue plasminogen activator therapy,
Meidi Peng, Yupei Chen, Guiling Geng
openaire   +2 more sources

Cystatin C

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2002
Clinical biochemists have long known the analytical and clinical limitations of creatinine and creatinine clearance measurement in the assessment of glomerular filtration rate (GFR). This background is reviewed in the article before assessing the utility of cystatin C, the most promising replacement biochemical marker yet identified.
openaire   +2 more sources

Cystatin C in Cerebrovascular Disorders

Current Neurovascular Research, 2018
Cystatin C (CysC), a cysteine protease inhibitor, has been widely proven to be a highly sensitive biomarker to predict the kidney function. The similarity of the renal and cerebral small vessels has awakened a surge of studies suggesting that CysC plays a key role in various cerebrovascular disorders.
Yaru, Zhang, Li, Sun
openaire   +2 more sources

Cystatin C in pre-eclampsia

The Journal of Maternal-Fetal & Neonatal Medicine, 2012
To evaluate diagnostic value of cystatin C serum levels as alternative marker of renal function in pre-eclamsia (PE) and compare it with the traditional markers of renal function, creatinine and uric acid. In order to investigate the possible influence of inflammation on biochemical markers of renal function, serum levels of high sensitive CRP were ...
Aleksandra, Novakov Mikic, Velibor, Cabarkapa, Aleksandra, Nikolic, Daniela, Maric, Snezana, Brkic, Gorana, Mitic, Marina, Ristic, Zoran, Stosic   +7 more
openaire   +2 more sources